LILLY ELI CO LLY (NYSE) $ 48.23 Change: +0.61 +1.28% | Volume: 3,168,418

LILLY ELI & CO - Fundamental Profile

Company Information

Ticker Symbol: LLY
Exchange: NYSE
Contact Info: Lilly Corporate Center Indianapolis IN 46285 317 276-2000
CEO/President: Sidney Taurel
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Share Information

Shares Outstanding: 1,136,980 (000) Market Value: 53,642,480 ($000)
Percentage of Inst.Shareholders: 75.28% Number of Inst.Shareholders: 0.18%
Last Quarter Sales: 4807.60 ($Mil.) Last Quarter Net Income: 1064.30 ($Mil.)
Last Quarter EPS: 0.92 P/E Ratio: 13
Most Recent Earnings: 0.92 on 04/21/08 Earnings Per Share: 3.21
Most Recent Split: 2-1 on 10/16/97 Annual Dividend Rate: 1.88
Most Recent Dividend: 0.470 on 05/13/08 Annual Dividend Yield: 3.98%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -17.00 19.07
MERCK CO INC -42.20 31.77
SCHERING PLOUGH -27.50 19.53
BRISTOL MYERS S -19.00 21.89
JOHNSON AND JOH +16.40 68.27